Screening of HIV infection: role of molecular and immunological assays

References

• Constantine NT, Zink H. HIV testing strategies after two decades of evolution. Indian J. Med. Res.121, 519–538 (2005).
   PubMed Web of Science ®Google Scholar
• Fiebig EW, Heldebrant CM, Smith RI, Conrad AJ, Delwart EL, Busch MP. Intermittent low-level viremia in very early primary HIV-1 infection. J. Acquir. Immune Defic. Syndr.39, 133–137 (2005).
   PubMedGoogle Scholar
• Weber B, Berger A, Rabenau H, Doerr HW. Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra. J. Clin. Microbiol.40, 1420–1426 (2002).
   PubMed Web of Science ®Google Scholar
• Murthy KK, Henrard DR, Eichberg JW et al. Redefining the HIV-infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission. Transfusion39, 688–693 (1999).
   PubMedGoogle Scholar
• Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N. Engl. J. Med.339, 33–39 (1998).
   PubMed Web of Science ®Google Scholar
• Fiebig EW, Wright DJ, Rawal BD et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS17, 1871–1879 (2003).
   PubMed Web of Science ®Google Scholar
• Quinn TC, Wawer MJ, Sewankambo N et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med.342, 921–929 (2000).
   PubMed Web of Science ®Google Scholar
• Van Gemen B, Kievits T, Schukkink R et al. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J. Virol. Methods43, 177–187 (1993).
   PubMedGoogle Scholar
• Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am. J. Med.102, 117–124 (1997).
   PubMedGoogle Scholar
• Stekler J, Collier AC. Primary HIV infection. Curr. HIV/AIDS Rep.2, 68–73 (2004).
   Google Scholar
• Busch MP, Kleinman SH, Jackson B, Stramer SL, Hewlett I, Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion40, 143–159 (2000).
   PubMed Web of Science ®Google Scholar
• Clark SJ, Kelen GD, Henrard DR et al. Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients. J. Infect. Dis.170, 194–197 (1994).
   PubMedGoogle Scholar
• Ly TD, Edlinger C, Vabret A. Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing. J. Clin. Microbiol.38, 2459–2461 (2000).
   PubMed Web of Science ®Google Scholar
• Rox JM, Eis-Hübinger AM, Muller J et al. First human immunodeficiency virus-1 Group O infection in a European blood donor. Vox Sang87, 44–45 (2004).
   PubMedGoogle Scholar
• Apetrei C, Loussert-Ajaka I, Descamps D et al. Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS10, 57–60 (1996).
   PubMed Web of Science ®Google Scholar
• Christiansen CB, Jessen TE, Nielsen C, Staun-Olsen P. False negative anti-HIV-1/HIV-2 ELISAs in acute HIV-2 infection. Vox Sang70, 144–147 (1996).
   PubMedGoogle Scholar
• Burin des Roziers N, Coste J, Courouce A, Bibollet-Ruche F, Guillard A, Nasr O. Detection of HIV-1 RNA in two consecutive blood donations screened negative for HIV antibodies. Vox Sang75, 298–302 (1998).
   PubMedGoogle Scholar
• Imagawa DT, Lee MH, Wolinsky SM et al. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N. Engl. J. Med.320, 1458–1462 (1989).
   PubMed Web of Science ®Google Scholar
• Weber B. Multicenter evaluation of the new automated Enzymun-Test anti HIV 1+2+ subtype O. J. Clin. Microbiol.36, 580–584 (1998).
   PubMedGoogle Scholar
• Ascher DP, Roberts Ch, Fowler A. Acidification modified p24 antigen capture assay in HIV seropositives. J. Aquired Immune Defic. Syndr.5, 1080–1083 (1992).
   PubMedGoogle Scholar
• Jongerius JM, Sjerps M, Cuijpers HT et al. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening. Transfusion42, 792–797 (2002).
   PubMedGoogle Scholar
• Candotti D, Richetin A, Cant B et al. Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system. Transfusion43, 215–225 (2003).
   PubMed Web of Science ®Google Scholar
• Lelie PN, van Drimmelen HA, Cuypers HT et al. Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion42, 527–536 (2002).
   PubMedGoogle Scholar
• Koppelman MH, Sjerps MC, Reesink HW, Cuypers HT. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection. Vox Sang89, 193–200 (2005).
   PubMedGoogle Scholar
• Mison L, Seed CR, Margaritis AR, Hyland C, Australian Red Cross Blood Service Nucleic Acid Technology Study Group. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies. Vox Sang84, 11–19 (2003).
   Google Scholar
• McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA. J. Clin Virol. (2006) (In Press).
   PubMedGoogle Scholar
• McAuley JD, Caglioti S, Williams RC et al. Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay. Transfusion44, 91–96 (2004).
   PubMedGoogle Scholar
• Busch MP, Glynn SA, Stramer SL et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion45, 254–264 (2005).
   PubMed Web of Science ®Google Scholar
• Pillonel J, Laperche S, Etablissement Francais du Sang. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill.10, 5–8 (2005).
   PubMedGoogle Scholar
• Offergeld R, Faensen D, Ritter S, Hamouda O. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000–2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill.10, 8–11 (2005).
   Google Scholar
• Velati C, Fomiatti L, Baruffi L, Romano L, Zanetti A, Gruppo Italiano per lo Studio delle Malattie Trasmissibili con la Trasfusione. Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001–2003). Euro Surveill.10, 2–4 (2005).
   Google Scholar
• Stramer SL, Glynn SA, Kleinman SH et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N. Engl. J. Med.351, 760–768 (2004).
   PubMed Web of Science ®Google Scholar
• Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost–effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion43, 721–729 (2003).
   PubMed Web of Science ®Google Scholar
• Barlow KL, Tosswill JHC, Parry JV, Clewley JP. Performance of the Amplicor human immunodeficiency virus type 1 PCR and analysis of specimens with false-negative results. J. Clin. Microbiol.35, 2846–2853 (1997).
   PubMed Web of Science ®Google Scholar
• Laperche S, Morel P, Deschaseaux M et al. HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation. Transfusion43, 1428–1432 (2003).
   PubMedGoogle Scholar
• Roth WK, Weber H, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood bank setting. Lancet353, 359–363 (1999).
   PubMedGoogle Scholar
• Le Corfec E, Le Pont F, Tuckwell HC, Rouzioux C, Costaglioa D. Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size. Transfusion39, 1141–1144 (1999).
   PubMedGoogle Scholar
• Quinn TC, Brookmeyer R, Kline R et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS14, 2751–2757 (2000).
   PubMed Web of Science ®Google Scholar
• Ling AE, Robbins KE, Brown TM et al. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA284, 210–214 (2000).
   PubMedGoogle Scholar
• Delwart EL, Kalmin ND, Jones TS et al. First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang86, 171–177 (2004).
   PubMed Web of Science ®Google Scholar
• Assal A, Coste J, Barlet V et al. Application of molecular biology to blood transfusion safety: the nucleic acid testing. Transfus. Clin. Biol.10, 217–226 (2003).
   PubMedGoogle Scholar
• Pilcher CD, Fiscus SA, Nguyen TQ et al. Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med.352, 1873–1883 (2005).
   PubMed Web of Science ®Google Scholar
• Aubuchon JP, Birkmeyer JD, Busch MP. Cost–effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion45, 45–51 (1997).
   Google Scholar
• Daar ES, Little S, Pitt J et al. Diagnosis of primary HIV infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann. Intern. Med.134, 75–77 (2001).
   PubMedGoogle Scholar
• Tersmette M, Winkel I, Groenick M et al. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24 gag. Virology171, 149–155 (1989).
   PubMedGoogle Scholar
• Van den Haesevelde M, Decourt JL, Deleys RJ et al. Genomic cloning and complete sequence analysis of highly divergent African human virus isolate. J. Virol.68, 1586–1596 (1994).
   PubMedGoogle Scholar
• Maniez M, Rouzioux C, Couroucé AM. Evaluation des trousses de dépistage de l’antigène p24 du VIH. Spectra Biologie16, 41–49 (1997).
   Google Scholar
• Weber B. Human immunodeficiency virus (HIV) antigen–antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J. Clin. Microbiol.40, 4402–4403 (2002).
   PubMedGoogle Scholar
• Gürtler L, Mühlbacher A, Michl U et al. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J. Virol. Methods75, 27–38 (1998).
   PubMed Web of Science ®Google Scholar
• Weber B, Fall EMB, Berger A, Doerr HW. Reduction of diagnostic window by new fourth- generation human immunodeficiency virus screening assays. J. Clin. Microbiol.36, 2235–2239 (1998).
   PubMed Web of Science ®Google Scholar
• Laperche S, Maniez-Montreuil M, Couroucé AM. Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1. Transfus. Clin. Biol.7, S18–S24 (2000).
   Google Scholar
• Weber B, Mühlbacher A, Michl U et al. Multicenter evaluation of a new rapid automated HIV antigen detection assay. J. Virol. Methods78, 61–70 (1999).
   PubMed Web of Science ®Google Scholar
• Ly TD, Martin L, Daghfal D et al. Seven human immunodeficiency virus (HIV) antigen–antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J. Clin. Microbiol.39, 3122–3128 (2001).
   PubMed Web of Science ®Google Scholar
• Weber B, Gurtler L, Thorstensson R et al. Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J. Clin. Microbiol.40, 1938–1946 (2002).
   PubMed Web of Science ®Google Scholar
• Weber B. A new automated fourth-generation HIV screening assay with sensitive antigen detection module and high specificity. Methods Mol. Biol.304, 245–255 (2005).
   PubMedGoogle Scholar
• Couroucé, AM, Groupe de Travail Rétrovirus de la SFTS. Tests de dépistage combiné des anticorps anti-VIH et de l’antigène p24. Gazette Transfus. Sang.155, 4–18 (1999).
   Google Scholar
• Meier T, Knoll E, Henkes M, Enders G, Braun R. Evidence for a diagnostic window in fourth generation assays for HIV. J. Clin Virol23, 113–116 (2001).
   PubMed Web of Science ®Google Scholar
• Weber B, Meier T, Enders G. Fourth generation human immunodeficiency virus (HIV) screening assays with an improved sensitivity for p24 antigen close the second diagnostic window in primary HIV infection. J. Clin Virol25, 357–359 (2002).
   PubMedGoogle Scholar
• Weber B, Thorstensson R, Tanprasert S, Schmitt U, Melchior W. Reduction of the diagnostic window in three cases of human immunodeficiency-1 subtype E primary infection with fourth-generation HIV screening assays. Vox Sang85, 73–79 (2003).
   PubMedGoogle Scholar
• Sickinger E, Stieler M, Kaufman B et al. Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen. J. Clin. Microbiol.42, 21–29 (2004).
   PubMedGoogle Scholar
• Andersson S, Asjo B, Jenum PA et al. Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in a low prevalence population: case reports. Clin. Lab.50, 409–413 (2004).
   PubMedGoogle Scholar
• McElborough D. Importance of using an HIV Ag/Ab combined assay in a UK population at high risk of acquiring HIV infection. Commun. Dis. Public Health7, 312–314 (2004).
   PubMedGoogle Scholar
• Brust S, Duttmann H, Feldner J, Gurtler L, Thorstensson R, Simon F. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. J. Virol. Methods90, 153–165 (2000).
   PubMed Web of Science ®Google Scholar
• Ly TD, Laperche S, Brennan C et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J. Virol. Methods122, 185–194 (2004).
   PubMed Web of Science ®Google Scholar
• Saville RD, Constantine NT, Cleghorn FR et al. Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody. J. Clin. Microbiol.39, 2518–2524 (2001).
   PubMed Web of Science ®Google Scholar
• Bourlet T, Pretis C, Pillet S, Lesenechal M, Piche J, Pozzetto B. Comparative evaluation of the VIDAS HIV DUO Ultra assay for combined detection of HIV-1 antigen and antibodies to HIV. J. Virol. Methods127, 165–167 (2005).
   PubMedGoogle Scholar
• Sutthent R, Gaudart N, Chokpaibulkit K, Tanliang N, Kanoksinsombath C, Chaisilwatana P. p24 antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J. Clin. Microbiol.41, 1016–1022 (2003).
   PubMed Web of Science ®Google Scholar
• Roland ME, Elbeik TA, Kahn JO et al. HIV RNA testing in the context of nonoccupational postexposure prophylaxis. J. Infect. Dis.190, 598–604 (2004).
   PubMed Web of Science ®Google Scholar
• Ly TD, Laperche S, Courouce AM. Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays. Eur. J. Clin. Microbiol. Infect. Dis.20, 104–110 (2001).
   PubMed Web of Science ®Google Scholar
• van Binsbergen J, Siebelink A, Jacobs A et al. Improved performance of seroconversion with a 4th generation HIV antigen/antibody assay. J. Virol. Methods82, 77–84 (1999).
   PubMedGoogle Scholar